BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnson AC, Farmer AD, Ness TJ, Greenwood-Van Meerveld B. Critical evaluation of animal models of visceral pain for therapeutics development: A focus on irritable bowel syndrome. Neurogastroenterol Motil 2020;32:e13776. [PMID: 31833625 DOI: 10.1111/nmo.13776] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Brierley SM, Grundy L, Castro J, Harrington AM, Hannig G, Camilleri M. Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain. Trends Pharmacol Sci 2021:S0165-6147(21)00217-0. [PMID: 34865885 DOI: 10.1016/j.tips.2021.11.002] [Reference Citation Analysis]
2 El-Salhy M, Valeur J, Hausken T, Gunnar Hatlebakk J. Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2021;33:e13983. [PMID: 32945066 DOI: 10.1111/nmo.13983] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Paine P. Review article: current and future treatment approaches for pain in IBS. Aliment Pharmacol Ther 2021;54 Suppl 1:S75-88. [PMID: 34927753 DOI: 10.1111/apt.16550] [Reference Citation Analysis]
4 Long JY, Wang XJ, Li XY, Kong XH, Yang G, Zhang D, Yang YT, Shi Z, Ma XP. Spinal Microglia and Astrocytes: Two Key Players in Chronic Visceral Pain Pathogenesis. Neurochem Res 2021. [PMID: 34797501 DOI: 10.1007/s11064-021-03486-9] [Reference Citation Analysis]
5 West C, McVey Neufeld KA. Animal models of visceral pain and the role of the microbiome. Neurobiol Pain 2021;10:100064. [PMID: 34151049 DOI: 10.1016/j.ynpai.2021.100064] [Cited by in F6Publishing: 1] [Reference Citation Analysis]